Annie Chou

Annie Chou is an Executive Director in Translational Medicine and Early Clinical Development at Organon, having previously served as Director of Early Clinical Development and Operations at Myovant Sciences. With a clinical background as a sub-investigator in autoimmunity trials and experience managing epidemiological studies at UCSF Medical Center, they have specialized training in Oral Medicine. Annie holds a DDS and a PhD in Oral and Craniofacial Sciences from the University of California, San Francisco, and a BA in Cell/Cellular and Molecular Biology from the University of California, Berkeley. They are recognized for their leadership in clinical operations, vendor management, and study design, complemented by strong writing skills in scientific documentation.